Dual-targeting class I HDAC inhibitor and ATM activator, SP-1-303, preferentially inhibits estrogen receptor positive breast cancer cell growth
Article in PLOS ONE (July 2024)
The most recent citing publications are shown below. View all 2 publications that cite this research output on Dimensions.
Article in PLOS ONE (July 2024)
Article in The FASEB Journal (June 2024)